# Aarti Drugs Ltd (AARTIDRUGS)
> Exchange: NSE | Sector: Pharma | ISIN: 

## Price
Current Price: ₹380.4
Day Change: -0.33%
52W High: ₹564.05
52W Low: ₹318.95
Market Cap: ₹3,340 Cr

## Valuation
P/E: 16.56
P/B: 2.46
EPS: ₹22.1
Book Value: ₹148.52
Dividend Yield: 0%

## Returns
1Y Return: -22.58%

## Profitability
ROE: 13.36%
ROCE: 12.52%
Debt/Equity: 0.37
Revenue Growth: 6.5%
Profit Growth: -12%
EBITDA Margin: 12.14%
Operating Margin: 10.89%

## About
Aarti Drugs Ltd is a Drug Manufacturers - Specialty & Generic company listed on NSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Pharma
Industry: Drug Manufacturers - Specialty & Generic
Sub Industry: Unknown

## Business Model
Overview: Aarti Drugs Ltd makes money through Domestic formulations, Exports and regulated markets, Specialty or institutional sales in Drug Manufacturers - Specialty & Generic. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Pharma.
Source: Derived from stock data
Revenue Streams:
- Domestic formulations
- Exports and regulated markets
- Specialty or institutional sales
Operating Model:
- Develops, manufactures, distributes, or services healthcare products across regulated channels.
- Approvals, product mix, compliance quality, and R&D productivity shape growth.
Recent Context:
- Investor Presentation: Announcement under Regulation 30 (LODR)-Investor Presentation
- Announcement: Announcement under Regulation 30 (LODR)-Press Release / Media Release
- BSE Filing: Announcement under Regulation 30 (LODR)-Press Release / Media Release

## Access
Current tier: anonymous
More history: Register free to see 8 more years.

## Data Freshness
Quote Updated: 2026-05-21T20:00:00.502Z
Price History Updated: 2026-05-17T21:23:44.837Z
Latest Price History Date: 2026-05-17
Technicals Updated: 2026-05-17T21:23:44.837Z
Quant Updated: 2026-05-17T21:23:44.837Z
Sentiment Updated: 2026-05-17T21:23:44.837Z
Financials Status: current
Financials Updated: 2026-05-18T15:30:27.264Z
Financials Last Attempt: 2026-05-18T15:30:27.264Z
Financials Provider Tried: yahoo
Latest P&L Period: FY25
Latest Balance Sheet Period: FY25
Latest Cash Flow Period: FY25

## P&L (Mar 2016)
Revenue: ₹1097 Cr
Operating Profit: ₹172 Cr (OPM 16%)
Net Profit: ₹77 Cr
Tax: ₹100 Cr

## Annual P&L History
Mar 2016: Rev ₹1097Cr | PAT ₹77Cr | OPM 16%
Mar 2017: Rev ₹1140Cr | PAT ₹69Cr | OPM 16%
Mar 2018: Rev ₹1195Cr | PAT ₹82Cr | OPM 16%

## Balance Sheet (Mar 2016)
Total Assets: ₹1004 Cr
Total Liabilities: ₹1004 Cr
Borrowings: ₹448 Cr
Cash: ₹undefined Cr

## Shareholding
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%

## Board
- Prakash Moreshwar Patil, Chairman, MD & CEO
- Harshit Manila Savla, Joint MD & Executive Director
- Adhish Prakash Patil, CFO & COO
- Rushikesh Vivek Deole, Company Secretary & Compliance Officer
- Harit Pragji Shah, Whole-Time Director

---
Source: rupiya.io/stocks/aartidrugs
Disclaimer: For research and education only. Not investment advice.